The present study showed that HPSE2, used as a single marker for DTC, achieved accuracy of 86.1%, as high as observed in the other three markers, without false-negative cases, which means this molecule has great potential as a marker in the differential diagnosis of thyroid nodule. This evidence concerns the gene HPSE2 and thyroid nodule.